The Centre of Research Excellence on Achieving the Tobacco Endgame (CREATE)

Estimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study

S Howe, T Wilson, K Morphett, K Mason, G Lai, VW Rees, D Ait Ouakrim

2026-06-01

Background People living in social housing in Australia have higher prevalence of daily smoking and greater exposure to second-han..

Trends in Noticing and Responding to, Health Warning Labels on Cigarette Packages Among Adults Who Smoke: Findings from the ITC Four Country Surveys Between 2002 and 2022

B Dhungel, R Borland, HH Yong, C Gartner, KA East, D Hammond, KM Cummings, A Hyland, M Bansal-Travers, A McNeill, S Gravely, GT Fong

2026-03-01

Introduction: We present data on 20-year (2002–2022) trends in reactions of smokers to Health Warning Label (HWL) changes (eg, inc..

Understanding the role of cessation fatigue in smoking relapse: Findings from the International Tobacco Control Four Country Smoking and Vaping Survey

HH Yong, R Borland, M Le Grande, CCY Hu, C Gartner, A Hyland, KM Cummings

2026-02-01

Background and Aim: Relapse risk among people who formerly smoke is influenced by task difficulty. Cessation fatigue (CF) may be a..

How is heated tobacco product use described by people who use them daily?

R Borland, B Dhungel, CE Gartner, GT Fong, A Hyland, KM Cummings, KA East

2026-01-01

Economic effects for citizens and the government of a country-level tobacco endgame strategy: a modelling study

D Ait Ouakrim, T Wilson, S Howe, P Clarke, CE Gartner, N Wilson, T Blakely

2025-12-01

Background Aotearoa-New Zealand (A/NZ) was the first country to pass a comprehensive commercial tobacco endgame strategy into law...

‘Every Touch Point Is an Opportunity’: Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program

NJ Harrison, D Riddiford-Harland, S York, HM Marshall, JJ Rhee, E Stone, ML Yap, AR Sharman, M Weber, SA McCullough, T Byrne, CL Paul, JA Bowden, B Bonevski, NM Rankin

2025-05-01

Background: Targeted lung cancer screening (LCS) presents unique opportunities for smoking cessation among high-risk individuals. ..

A novel tobacco forecasting model by multiple sociodemographic strata in Australia

S Howe, T Wilson, C Gartner, T Blakely, D Ait Ouakrim

2025-04-01

Background: Australia is one of several countries aiming to achieve a commercial tobacco endgame, with a current target of ≤5% dai..

"Because That is the Right Thing to do": A Focus Group Study of Australian Expert Perspectives on Offering Smoking Cessation Support in Lung Cancer Screening

NJ Harrison, RH Dodd, AR Sharman, HM Marshall, E Stone, JJ Rhee, ML Yap, S McCullough, C Paul, JA Bowden, B Bonevski, NM Rankin

2025-03-01

Introduction: Lung cancer screening (LCS) trials, targeting people with a smoking history, have demonstrated reduced mortality. Ho..

Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour

S Wade, P Sarich, P Vaneckova, S Behar-Harpaz, PJ Ngo, PB Grogan, S Cressman, CE Gartner, JM Murray, T Blakely, E Banks, MC Tammemagi, K Canfell, MF Weber, M Caruana

2025-03-01

Simulation models of smoking behaviour provide vital forecasts of exposure to inform policy targets, estimates of the burden of di..

Modelling the potential impacts of limiting vaping product sales to pharmacies

D Ait Ouakrim, T Wilson, S Howe, J Summers, R Edwards, CE Gartner, N Wilson, T Blakely

2025-01-01

Background: Vaping rates are increasing globally. Restricting vaping products' access may result in net population health loss if ..

A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia

J Trigg, J Rich, E Williams, A Baker, L Bauld, R Borland, C Bullen, M Daglish, A Dunlop, C Gartner, D Jacka, D Lubman, V Manning, R McCrohan, C Segan, N Walker, B Bonevski

2024-07-01

Introduction: Tobacco smoking is highly prevalent among alcohol and other drugs (AOD) service clients and, despite interest in qui..

Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?

Ron Borland, Michael Le Grande, Coral Gartner, Kylie Morphett

2024-06-01

BACKGROUND: In Australia, nicotine vaping products (NVPs) are only legally available to those with a prescription from a doctor. W..

Future nicotine use preferences of current cigarette smokers: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey

L Li, R Borland, M Le Grande, C Gartner

2024-02-01

Introduction: Consumer preferences should be important factors that are considered when developing health policies and interventio..

Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys

HH Yong, S Gravely, R Borland, C Gartner, KM Cummings, K East, S Tagliaferri, T Elton-Marshall, A Hyland, M Bansal-Travers, GT Fong

2022-09-01

Introduction: This study examined whether smokers' harm perceptions of nicotine replacement therapy (NRT) and nicotine vaping prod..

Closing the gaps in tobacco endgame evidence: a scoping review

C Puljević, K Morphett, M Hefler, R Edwards, N Walker, DP Thomas, MA Khan, A Perusco, M Le Grande, K Cullerton, D Ait Ouakrim, G Carstensen, D Sellars, J Hoek, R Borland, B Bonevski, T Blakely, C Brolan, CE Gartner

2022-03-01

Objective Tobacco endgame policies aim to rapidly and permanently reduce smoking to minimal levels. We reviewed evidence syntheses..